Galit Meshulam-Simon holds a PhD from the Technion - Israel Institute of Technology in

biotechnology and heads the Commercial Applications team at Elegen. With over 17 years of expertise leading R&D teams, Meshulam-Simon’s career spans different aspects of synthetic biology, protein engineering, infectious disease diagnostics, and AI-driven enzyme discovery to drive innovations and partnerships in synthetic biology, molecular diagnostics, and genetics medicine development.